Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Enhancing Electrocatalytic Water Splitting by Strain Engineering.

You B, Tang MT, Tsai C, Abild-Pedersen F, Zheng X, Li H.

Adv Mater. 2019 Apr;31(17):e1807001. doi: 10.1002/adma.201807001. Epub 2019 Feb 18. Review.

PMID:
30773741
2.

Investigation of Cavity Enhanced XEOL of a Single ZnO Microrod by Using Multifunctional Hard X-ray Nanoprobe.

Lin BH, Li XY, Lin DJ, Jian BL, Hsu HC, Chen HY, Tseng SC, Lee CY, Chen BY, Yin GC, Hsu MY, Chang SH, Tang MT, Hsieh WF.

Sci Rep. 2019 Jan 18;9(1):207. doi: 10.1038/s41598-018-36764-8.

3.

Rumen fluid, feces, milk, water, feed, airborne dust, and bedding microbiota in dairy farms managed by automatic milking systems.

Wu H, Nguyen QD, Tran TTM, Tang MT, Tsuruta T, Nishino N.

Anim Sci J. 2019 Mar;90(3):445-452. doi: 10.1111/asj.13175. Epub 2019 Jan 17.

PMID:
30656804
4.

Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease.

Tang MT, Keir ME, Erickson R, Stefanich EG, Fuh FK, Ramirez-Montagut T, McBride JM, Danilenko DM.

Aliment Pharmacol Ther. 2018 Jun;47(11):1440-1452. doi: 10.1111/apt.14631. Epub 2018 Mar 30. Review.

5.

Peculiar near-band-edge emission of polarization-dependent XEOL from a non-polar a-plane ZnO wafer.

Lin BH, Wu YC, Chen HY, Tseng SC, Wu JX, Li XY, Chen BY, Lee CY, Yin GC, Chang SH, Tang MT, Hsieh WF.

Opt Express. 2018 Feb 5;26(3):2731-2739. doi: 10.1364/OE.26.002731.

PMID:
29401809
6.

Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis.

Wei X, Gibiansky L, Wang Y, Fuh F, Erickson R, O'Byrne S, Tang MT.

J Clin Pharmacol. 2018 Mar;58(3):386-398. doi: 10.1002/jcph.1031. Epub 2017 Nov 26.

7.

Variability, stability, and resilience of fecal microbiota in dairy cows fed whole crop corn silage.

Tang MT, Han H, Yu Z, Tsuruta T, Nishino N.

Appl Microbiol Biotechnol. 2017 Aug;101(16):6355-6364. doi: 10.1007/s00253-017-8348-8. Epub 2017 Jun 10.

PMID:
28601892
8.

Diversity of lactic acid bacteria in vegetable-based and meat-based fermented foods produced in the central region of Vietnam.

Phan YTN, Tang MT, Tran TTM, Nguyen VH, Nguyen TH, Tsuruta T, Nishino N.

AIMS Microbiol. 2017 Feb 7;3(1):61-70. doi: 10.3934/microbiol.2017.1.61. eCollection 2017.

9.

Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.

Chen L, Li CI, Tang MT, Porter P, Hill DA, Wiggins CL, Cook LS.

Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1297-304. doi: 10.1158/1055-9965.EPI-15-1104. Epub 2016 Jun 15.

10.

Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.

Chen L, Cook LS, Tang MT, Porter PL, Hill DA, Wiggins CL, Li CI.

Breast Cancer Res Treat. 2016 Jun;157(3):545-54. doi: 10.1007/s10549-016-3825-9. Epub 2016 May 24.

11.

Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.

Wang Y, Zhu R, Xiao J, Davis JC Jr, Mandema JW, Jin JY, Tang MT.

J Clin Pharmacol. 2016 Jul;56(7):835-44. doi: 10.1002/jcph.668. Epub 2015 Dec 31.

12.

Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis.

Wei X, Kenny JR, Dickmann L, Maciuca R, Looney C, Tang MT.

J Clin Pharmacol. 2016 Jun;56(6):693-704. doi: 10.1002/jcph.649. Epub 2016 Jan 11.

13.

Effective increase in beam emittance by phase-space expansion using asymmetric Bragg diffraction.

Chu CH, Tang MT, Chang SL.

Opt Express. 2015 Aug 24;23(17):21719-29. doi: 10.1364/OE.23.021719.

PMID:
26368150
14.

FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.

Lehrer-Graiwer J, Singh P, Abdelbaky A, Vucic E, Korsgren M, Baruch A, Fredrickson J, van Bruggen N, Tang MT, Frendeus B, Rudd JHF, Hsieh F, Ballantyne CM, Ghoshhajra B, Rosenson RS, Koren M, Roth EM, Duprez DA, Fayad ZA, Tawakol AA.

JACC Cardiovasc Imaging. 2015 Apr;8(4):493-494. doi: 10.1016/j.jcmg.2014.06.021. Epub 2014 Nov 12. No abstract available.

15.

Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study).

Kennedy WP, Simon JA, Offutt C, Horn P, Herman A, Townsend MJ, Tang MT, Grogan JL, Hsieh F, Davis JC.

Arthritis Res Ther. 2014 Oct 30;16(5):467. doi: 10.1186/s13075-014-0467-3.

16.
17.

Interferometric time-stretch microscopy for ultrafast quantitative cellular and tissue imaging at 1 μm.

Lau AK, Wong TT, Ho KK, Tang MT, Chan AC, Wei X, Lam EY, Shum HC, Wong KK, Tsia KK.

J Biomed Opt. 2014;19(7):76001. doi: 10.1117/1.JBO.19.7.076001.

18.

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.

Vermeire S, O'Byrne S, Keir M, Williams M, Lu TT, Mansfield JC, Lamb CA, Feagan BG, Panes J, Salas A, Baumgart DC, Schreiber S, Dotan I, Sandborn WJ, Tew GW, Luca D, Tang MT, Diehl L, Eastham-Anderson J, De Hertogh G, Perrier C, Egen JG, Kirby JA, van Assche G, Rutgeerts P.

Lancet. 2014 Jul 26;384(9940):309-18. doi: 10.1016/S0140-6736(14)60661-9. Epub 2014 May 9.

19.

Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.

Li CI, Daling JR, Haugen KL, Tang MT, Porter PL, Malone KE.

Breast Cancer Res Treat. 2014 Jun;145(2):481-9. doi: 10.1007/s10549-014-2960-4. Epub 2014 Apr 20.

20.

Antihypertensive medications and breast cancer risk-reply.

Li CI, Tang MT, Malone KE.

JAMA Intern Med. 2014 Apr;174(4):641. doi: 10.1001/jamainternmed.2013.13740. No abstract available.

PMID:
24711189
21.

Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.

Beaber EF, Malone KE, Tang MT, Barlow WE, Porter PL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):755-64. doi: 10.1158/1055-9965.EPI-13-0944. Epub 2014 Mar 14.

22.

Improvement in pH sensitivity of low-temperature polycrystalline-silicon thin-film transistor sensors using H2 sintering.

Yen LC, Tang MT, Chang FY, Pan TM, Chao TS, Lee CH.

Sensors (Basel). 2014 Feb 25;14(3):3825-32. doi: 10.3390/s140303825.

23.

Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years.

Kawai M, Malone KE, Tang MT, Li CI.

Cancer. 2014 Apr 1;120(7):1026-34. doi: 10.1002/cncr.28402. Epub 2014 Feb 10.

24.
25.

Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.

Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE.

JAMA Intern Med. 2013 Sep 23;173(17):1629-37. doi: 10.1001/jamainternmed.2013.9071.

26.

Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.

Zhang Y, McClellan M, Efros L, Shi D, Bielekova B, Tang MT, Vexler V, Sheridan JP.

Mult Scler. 2014 Feb;20(2):156-64. doi: 10.1177/1352458513494488. Epub 2013 Jul 11.

27.

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Breast Cancer Res Treat. 2013 Jan;137(2):579-87. doi: 10.1007/s10549-012-2365-1. Epub 2012 Dec 9.

28.

6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest.

Zhang P, Chen JH, Dong X, Tang MT, Gao LY, Zhao GS, Yu LG, Guo XL.

Biomed Pharmacother. 2013 Feb;67(1):58-65. doi: 10.1016/j.biopha.2012.10.011. Epub 2012 Nov 19.

PMID:
23201007
29.

Relating the composition of Pt(x)Ru(100-x)/C nanoparticles to their structural aspects and electrocatalytic activities in the methanol oxidation reaction.

Taufany F, Pan CJ, Lai FJ, Chou HL, Sarma LS, Rick J, Lin JM, Lee JF, Tang MT, Hwang BJ.

Chemistry. 2013 Jan 14;19(3):905-15. doi: 10.1002/chem.201202473. Epub 2012 Nov 29.

PMID:
23197430
30.

Dynamical diffraction effect in a curved multi-plate crystal cavity.

Chang YY, Tsai YW, Wu YH, Tang MT, Chang SL.

Acta Crystallogr A. 2012 Nov;68(Pt 6):729-35. doi: 10.1107/S0108767312034319. Epub 2012 Oct 5.

PMID:
23075615
31.

Water-soluble constituents of the heartwood of Streblus asper.

Li J, Tang MT, Wu Q, Chen H, Niu XT, Guan XL, Li J, Deng SP, Su XJ, Yang RY.

Nat Prod Commun. 2012 May;7(5):599-602.

PMID:
22799085
32.

Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Cancer Res. 2012 Apr 15;72(8):2028-35. doi: 10.1158/0008-5472.CAN-11-4064. Epub 2012 Feb 27.

33.

Anti-HBV activities of Streblus asper and constituents of its roots.

Chen H, Li J, Wu Q, Niu XT, Tang MT, Guan XL, Li J, Yang RY, Deng SP, Su XJ.

Fitoterapia. 2012 Jun;83(4):643-9. doi: 10.1016/j.fitote.2012.01.009. Epub 2012 Jan 27.

PMID:
22305944
34.

Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.

Emu B, Luca D, Offutt C, Grogan JL, Rojkovich B, Williams MB, Tang MT, Xiao J, Lee JH, Davis JC.

Arthritis Res Ther. 2012 Jan 8;14(1):R6. doi: 10.1186/ar3554.

35.

Kinetically controlled autocatalytic chemical process for bulk production of bimetallic core-shell structured nanoparticles.

Taufany F, Pan CJ, Rick J, Chou HL, Tsai MC, Hwang BJ, Liu DG, Lee JF, Tang MT, Lee YC, Chen CI.

ACS Nano. 2011 Dec 27;5(12):9370-81. doi: 10.1021/nn202545a. Epub 2011 Nov 9.

PMID:
22047129
36.

Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.

Monsees GM, Malone KE, Tang MT, Newcomb PA, Li CI.

J Natl Cancer Inst. 2011 Dec 7;103(23):1752-60. doi: 10.1093/jnci/djr399. Epub 2011 Oct 21.

37.

Relating structural aspects of bimetallic Pt(3)Cr(1)/C nanoparticles to their electrocatalytic activity, stability, and selectivity in the oxygen reduction reaction.

Taufany F, Pan CJ, Chou HL, Rick J, Chen YS, Liu DG, Lee JF, Tang MT, Hwang BJ.

Chemistry. 2011 Sep 12;17(38):10724-35. doi: 10.1002/chem.201100556. Epub 2011 Aug 11.

PMID:
21837730
38.

Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis.

Sheridan JP, Zhang Y, Riester K, Tang MT, Efros L, Shi J, Harris J, Vexler V, Elkins JS.

Mult Scler. 2011 Dec;17(12):1441-8. doi: 10.1177/1352458511414755. Epub 2011 Aug 1.

PMID:
21807759
39.

Hypoglycemic effects and constituents of the barks of Cyclocarya paliurus and their inhibiting activities to glucosidase and glycogen phosphorylase.

Li S, Li J, Guan XL, Li J, Deng SP, Li LQ, Tang MT, Huang JG, Chen ZZ, Yang RY.

Fitoterapia. 2011 Oct;82(7):1081-5. doi: 10.1016/j.fitote.2011.07.002. Epub 2011 Jul 19.

PMID:
21784137
40.

ACTN3 genotype and swimming performance in Taiwan.

Chiu LL, Wu YF, Tang MT, Yu HC, Hsieh LL, Hsieh SS.

Int J Sports Med. 2011 Jun;32(6):476-80. doi: 10.1055/s-0030-1263115. Epub 2011 Apr 6.

PMID:
21472630
41.

Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development.

Lee JW, Kelley M, King LE, Yang J, Salimi-Moosavi H, Tang MT, Lu JF, Kamerud J, Ahene A, Myler H, Rogers C.

AAPS J. 2011 Mar;13(1):99-110. doi: 10.1208/s12248-011-9251-3. Epub 2011 Jan 15. Review.

42.

Relationship between diabetes and risk of second primary contralateral breast cancer.

Li CI, Daling JR, Tang MT, Malone KE.

Breast Cancer Res Treat. 2011 Jan;125(2):545-51. doi: 10.1007/s10549-010-1035-4. Epub 2010 Jul 13.

43.

Diffraction-enhanced beam-focusing for X-rays in curved multi-plate crystal cavity.

Chang YY, Chen SY, Wu HH, Weng SC, Chu CH, Lee YR, Tang MT, Stetsko Y, Shew BY, Yabashi M, Chang SL.

Opt Express. 2010 Apr 12;18(8):7886-92. doi: 10.1364/OE.18.007886.

PMID:
20588629
44.

Heavy metal removal and crude bio-oil upgrade from Sedum alfredii Hance harvest using hydrothermal upgrading.

Yang JG, Tang CB, He J, Yang SH, Tang MT.

J Hazard Mater. 2010 Jul 15;179(1-3):1037-41. doi: 10.1016/j.jhazmat.2010.03.109. Epub 2010 Apr 2.

PMID:
20409636
45.

Longitudinal study of recreational physical activity in breast cancer survivors.

Littman AJ, Tang MT, Rossing MA.

J Cancer Surviv. 2010 Jun;4(2):119-27. doi: 10.1007/s11764-009-0113-2. Epub 2010 Feb 24.

PMID:
20180037
46.

The modulated structure and ferromagnetic insulating state in a nine-layer BaRuO(3).

Du CH, Yao CH, Ling DC, Tang MT, Hsu FC, Liu HL, Hatton PD, Ikeda N.

J Phys Condens Matter. 2010 Jan 27;22(3):036003. doi: 10.1088/0953-8984/22/3/036003. Epub 2009 Dec 21.

PMID:
21386301
47.

Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.

Li CI, Daling JR, Porter PL, Tang MT, Malone KE.

J Clin Oncol. 2009 Nov 10;27(32):5312-8. doi: 10.1200/JCO.2009.23.1597. Epub 2009 Sep 8.

48.

Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.

Li CI, Daling JR, Porter PL, Tang MT, Malone KE.

Cancer Res. 2009 Sep 1;69(17):6865-70. doi: 10.1158/0008-5472.CAN-09-1355. Epub 2009 Aug 25. Erratum in: Cancer Res. 2010 Jan 15;70(2):853. Cancer Res. 2010 Mar 1;70(5):2140.

49.

Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.

Ng CM, Bai S, Takimoto CH, Tang MT, Tolcher AW.

Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17. doi: 10.1007/s00280-009-1023-8.

PMID:
19468731
50.

A dedicated small-angle X-ray scattering beamline with a superconducting wiggler source at the NSRRC.

Liu DG, Chang CH, Liu CY, Chang SH, Juang JM, Song YF, Yu KL, Liao KF, Hwang CS, Fung HS, Tseng PC, Huang CY, Huang LJ, Chung SC, Tang MT, Tsang KL, Huang YS, Kuan CK, Liu YC, Liang KS, Jeng US.

J Synchrotron Radiat. 2009 Jan;16(Pt 1):97-104. doi: 10.1107/S0909049508034134. Epub 2008 Nov 14.

PMID:
19096180

Supplemental Content

Support Center